← Back to Search

A for Ocular Hypertension

N/A
Waitlist Available
Led By Vladimir S Yakopson, MD
Research Sponsored by Walter Reed Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

The purpose of the study is to compare the safety and efficacy of two drops used to lower eye pressure when given prior to a glaucoma laser procedure.

Eligible Conditions
  • Ocular Hypertension
  • Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postoperative IOP
Secondary outcome measures
Overall IOP reduction post SLT

Trial Design

2Treatment groups
Active Control
Group I: AActive Control1 Intervention
Eyes receiving Brimonidine 0.1% (Alphagan) prior to SLT
Group II: IActive Control1 Intervention
Eyes receiving Apraclonidine 0.5% (Iopidine) prior to SLT

Find a Location

Who is running the clinical trial?

Walter Reed Army Medical CenterLead Sponsor
69 Previous Clinical Trials
20,896 Total Patients Enrolled
Vladimir S Yakopson, MDPrincipal InvestigatorWalter Reed AMC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025